The proposal to introduce a new European Biotech Act is very welcome. Biotechnology is a real area of strength for the EU, but there are widespread concerns that the European biotech sector is not realizing its full potential, that it remains too difficult to bring new products to market, and that the EU will be out-innovated by other countries and regions in the future.
IAVI
NGO · Netherlands · EU Transparency Register 685996941523-19
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 784 non-governmental organisations on this site, they rank #633 by legislative files engaged — a count of participation, not a measure of influence.
Declares membership of
- IAVI has no members and does not have formal memberships to other organization
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
- Register category
- Non-governmental organisations
- Registered as
- The International Aids Vaccine Initiative Inc (IAVI)
- Head office
- New York, United states
- EU office
- Amsterdam
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track IAVI in PolicySpeak: request access →
Work at IAVI? so we know who speaks for it.
Their record over time
IAVI filed 1 position on 11 Jun 2025, across 1 of the 326 legislative files tracked here.
What they argued
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Is this your organization?
Everything on this page comes from IAVI’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.